-+ 0.00%
-+ 0.00%
-+ 0.00%

LIMINATUS PHARMA ANNOUNCES PLANNED PHASE 1 CLINICAL TRIAL OF IBA101, A NEXT-GENERATION CD47 BLOCKING ANTIBODY

Reuters·03/17/2026 12:08:00

Please log in to view news